Drug Profile
Chikungunya vaccine - Takeda/Zydus Cadila
Alternative Names: TAK 507Latest Information Update: 22 Oct 2021
Price :
$50
*
At a glance
- Originator Takeda; Zydus Cadila
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Chikungunya virus infections